Valneva dips as French health authority advises against COVID shot

Dec. 08, 2022 7:09 AM ETValneva SE (VALN), DVAXGSK, SNY, NVAX, SNYNFBy: Dulan Lokuwithana, SA News Editor

Hand in blue medical gloves holding a syringe and vaccine vial with Covid 19 Vaccine Booster text, for Coronavirus booster shot.


Shares of France-based biotech Valneva SE (NASDAQ:VALN) trended lower in European trading after France's public health body Haute Autorité de santé (HAS) advised against the use of the company's COVID-19 vaccine as part of a broader immunization drive.

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.